Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer, Endometrial”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00006377
What this trial is testing

Doxorubicin, Paclitaxel, and Carboplatin in Treating Patients With Primary Stage III, Stage IV, or Recurrent Endometrial Cancer

Who this might be right for
Endometrial Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT01251354
What this trial is testing

Study of BN83495 in Post-menopausal Women With Endometrial Cancer Post-chemotherapy

Who this might be right for
Endometrial Cancer
Ipsen 6
Testing effectiveness (Phase 2)Looking for participantsNCT04716686
What this trial is testing

Niraparib Monotherapy as Maintain and Recurrent Treatment of Endometrial Serous Carcinoma

Who this might be right for
Endometrial CarcinomaSerous Carcinoma
Shandong University 83
Testing effectiveness (Phase 2)UnknownNCT02982486
What this trial is testing

A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma

Who this might be right for
Soft Tissue SarcomaBone SarcomaChondrosarcoma+5 more
Assaf-Harofeh Medical Center 60
Early research (Phase 1)Looking for participantsNCT07114601
What this trial is testing

LY4257496 in Participants With Cancer (OMNIRAY)

Who this might be right for
Breast NeoplasmsColorectal NeoplasmsProstate Neoplasm+4 more
Eli Lilly and Company 421
Not applicableLooking for participantsNCT07702799
What this trial is testing

Low-Residue Diet Versus Rectal Enema Before Laparoscopic Surgery for Endometrial Cancer

Who this might be right for
Endometrial Cancer
Mahmut Yassa 100
Post-approval studies (Phase 4)UnknownNCT02140398
What this trial is testing

Endometrial Scratching During Laproscopic Ovarian Drilling in Subfertile PCOS Women

Who this might be right for
InfertilityPolycystic Ovarian Syndrome
Mansoura University 500
Testing effectiveness (Phase 2)Study completedNCT04463771
What this trial is testing

Safety and Efficacy of Retifanlimab (INCMGA00012) Alone or in Combination With Other Therapies in Participants With Advanced or Metastatic Endometrial Cancer Who Have Progressed on or After Platinum-based Chemotherapy.

Who this might be right for
Endometrial Cancer
Incyte Corporation 206
Early research (Phase 1)Temporarily pausedNCT05958199
What this trial is testing

NPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7

Who this might be right for
Metastatic Malignant Neoplasm
NextPoint Therapeutics, Inc. 131
Not applicableUnknownNCT05634798
What this trial is testing

An Observational Study Based on Endometrial Cancer Risk Screening Model

Who this might be right for
Endometrial Neoplasms
Peking Union Medical College Hospital 2,000
Testing effectiveness (Phase 2)UnknownNCT02560571
What this trial is testing

Pre-operative Studies for Prediction of Lymph Nodes Involvement in Endometrial Cancer Patients

Who this might be right for
Endometrial Cancer
Meir Medical Center 200
Not applicableStudy completedNCT04025229
What this trial is testing

High Intensity Interval Training in Endometrial Cancer

Who this might be right for
Endometrial Cancer
UNC Lineberger Comprehensive Cancer Center 30
Not applicableUnknownNCT05669872
What this trial is testing

Patient Blood Mangement (PBM) Using IV Iron in Patients With Gynecologic Cancer

Who this might be right for
Gynecologic Cancer
Asan Medical Center 334
Not applicableStudy completedNCT00750672
What this trial is testing

Follow-up Care After Treatment for Endometrial Cancer

Who this might be right for
Endometrial Neoplasm
Ottawa Hospital Research Institute 20
Testing effectiveness (Phase 2)Study completedNCT00334295
What this trial is testing

Fulvestrant for the Treatment of Recurrent or Metastatic Endometrial Carcinoma.

Who this might be right for
Endometrial Carcinoma
AstraZeneca 35
Early research (Phase 1)Looking for participantsNCT07106827
What this trial is testing

GV20-0251 in Advanced or Refractory Solid Tumors

Who this might be right for
HCC - Hepatocellular CarcinomaCholangiocarcinomaMelanoma+5 more
West China Hospital 10
Testing effectiveness (Phase 2)Ended earlyNCT02059265
What this trial is testing

Dasatinib in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, Endometrial or Peritoneal Cancer

Who this might be right for
Endometrial Clear Cell AdenocarcinomaOvarian Clear Cell CystadenocarcinomaRecurrent Fallopian Tube Carcinoma+3 more
National Cancer Institute (NCI) 35
Not applicableUnknownNCT03979612
What this trial is testing

Evaluation of the Adhesion to the GENEPY Network

Who this might be right for
Hereditary Cancer SyndromeHereditary Breast and Ovarian CancerHereditary Colorectal Endometrial Cancer Syndrome
Institut Claudius Regaud 450
Not applicableStudy completedNCT02912767
What this trial is testing

Prevalence of Self Reported Lymphedema in Patients With Endometrial Cancer

Who this might be right for
Endometrial CancerLymphedema
Memorial Sloan Kettering Cancer Center 625
Early research (Phase 1)Looking for participantsNCT06400472
What this trial is testing

Sofe-M in Participants With Selected Advanced Solid Tumors

Who this might be right for
Ovarian NeoplasmsEndometrial NeoplasmsUterine Cervical Neoplasms+4 more
Eli Lilly and Company 575
Next Page